@steve-dragoo
-
Maureen Charles joined the group
Research and Development 1 week, 3 days ago
-
Judy Palac joined the group
Research and Development 3 weeks, 3 days ago
-
Ina Enslin joined the group
Research and Development 4 weeks ago
-
Steve James joined the group
Research and Development 1 month, 2 weeks ago
-
Steve Dragoo replied to the topic Use of Aspirin. in the forum
Research and Development 1 month, 3 weeks ago
Hi Joe,
I just posted a long answer here but it looks like it disappeared. Please let me know if you can see it. Otherwise, I will try to recreate it for you.
Stay well…
Steve -
Jofac O'Handlin replied to the topic Use of Aspirin. in the forum
Research and Development 1 month, 3 weeks ago
<p style=”text-align: left;”>Hi Steve, I missed the paper that you refer to, I only caught the study on mice that appeared on this site at the end of February (?). Is it the same paper or a different test. If different do you have a link.</p>
I have will have completed 3 weeks on my trial next Monday. Presently taking 75 mg coated tablets 3 times…[Read more] -
Islam Ahmed joined the group
Research and Development 2 months ago
-
Sheila D joined the group
Research and Development 2 months ago
-
Rachael joined the group
Research and Development 2 months ago
-
Steve Dragoo replied to the topic Use of Aspirin. in the forum
Research and Development 2 months ago
Hi Joe,
I’ve been taking baby aspirin enteric coated for a very long time. After a white paper was published here sometime last year, I increased to 3 baby aspirin 2x with no noticeable side effects and I take many other supplements as well.
Stay well…
Steve -
Scott Robertson joined the group
Research and Development 2 months ago
-
Jofac O'Handlin started the topic Use of Aspirin. in the forum
Research and Development 2 months ago
Hello all,
I posted a comment on the use of aspirin on the IPF News ‘Research and development’ site, saying that I was going to start with low dose, 75mg, gastro resistant tablets.
Being aware of the Gastro-intestinal (GI) risks of taking aspirin in as a prophylactic, I thought, ‘is there another mechanism of administration’.
After some internet…[Read more] -
Jofac O'Handlin posted an update in the group
Research and Development 2 months, 1 week ago
Hi All, i have eventually found my way in to make a comment, indicative of my lack of internet skills.
OK, I would like to expess some thought on the Aspirin article. I am in late stage IPF, it will be 10 years in August since diagnosis and started Nintedanib in May ’15.
Over the Christmas festivities I had an exacerbation which was a fundamental…[Read more] -
Jofac O'Handlin joined the group
Research and Development 2 months, 1 week ago
-
Stephen B. Strum, MD joined the group
Research and Development 2 months, 2 weeks ago
-
Michael Burd posted an update in the group
Research and Development 2 months, 2 weeks ago
Nintedanib and Perfenidone COMBINED therapy.
As these two drugs attack IPF in different ways there is consensus that taking both will produce better results than monotherapy. I would love to hear from anyone who has any recent testing information. -
Jamie joined the group
Research and Development 3 months ago
-
Monica Loftin joined the group
Research and Development 3 months, 1 week ago
-
Ozzie joined the group
Research and Development 4 months ago
-
Alan Stilley joined the group
Research and Development 4 months, 1 week ago
- Load More